PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Sedat Ballıkaya

Istanbul University-Cerrahpaşa

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 12, 2026 · JOURNAL ARTICLE

Development and In Vitro Validation of a Mobile 13.56 MHz Radiofrequency Hyperthermia Platform in Cancer Cell Models

Applied Sciences

First-generation technical development with in vitro proof-of-concept in cancer cell lines; lacks clinical outcome, adequate power analysis, or comparative control to support stronger evidence classification.

PreliminaryM. S. Iyikesici Sedat Ballıkaya Serap Erdem Kuruca

Reported

Temperature range achieved40 to 50 °C

RF power levels tested40 W and 50 W

Exposure duration10 min

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support